BioSpace News Archive

Business

Bellerophon Provides Clinical Program Update and Reports Third Quarter 2022 Financial Results

Bellerophon Therapeutics, Inc. today provided a clinical program update and reported financial results for the third quarter ended September 30, 2022.

November 14, 2022
·
9 min read
Genetown

Vicarious Surgical to Participate in Upcoming Conferences

Vicarious Surgical Inc. today announced that the company will be participating in the following upcoming investor conferences.

November 14, 2022
·
1 min read
Business

RenovoRx Reports Third Quarter 2022 Financial Results

RenovoRx, Inc today reported its financial results for the quarter ended September 30, 2022.

November 14, 2022
·
8 min read
Drug Development

ADDF Statement on Topline Results of Phase 3 Trials of Amyloid-Clearing Antibody Gantenerumab

The Alzheimer’s Drug Discovery Foundation (ADDF) remains incredibly enthusiastic about the current state of drug development for Alzheimer’s despite the negative results reported today by Roche for their amyloid-clearing drug gantenerumab in the phase 3 Graduate clinical trials.

November 14, 2022
·
3 min read
PreveCeutical Announces Conversion of Debt

Vancouver, British Columbia--(Newsfile Corp. - November 11, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), announces that it has entered into an assignment agreement with a certain arm’s length assignee (the “Assignee”).

November 14, 2022
·
5 min read
PathogenDx Debuts Octa(TM) AutoPrep Station: a Simple, Easy-To-Use Automated Sample Prep Solution for the Cannabis and Hemp Testing Sector

Supporting the Company’s Suite of Compatible AOAC-Certified Assays, the Octa™AutoPrep Station Delivers 73% Lower Labor Costs, Up to 8x Less Consumable Waste

November 14, 2022
·
4 min read
Live Cell Encapsulation Market Size - Quantitative Research By QYResearch Medical

The global live cell encapsulation market size was USD 269 million in 2020 and is expected to register a CAGR of 3.6% during the forecast period

November 14, 2022
·
8 min read
Immunofluorescence Assay (IFA) Market Size up to 2030 - Quantitative Research by QYResearch Medical

The global immunofluorescence assay (IFA) market size was USD 2.45 billion in 2020 and is expected to register a CAGR of 6.3% during the forecast period.

November 14, 2022
·
11 min read
In Vivo Toxicology Market Size 2022 to 2030 - Quantitative Research by QYResearch Medical

The global in vivo toxicology market size was USD 5.0 billion in 2020 and is expected to register a CAGR of 5.4% during the forecast period.

November 14, 2022
·
7 min read
Lung In Vitro Model Market Size up to 2030 - Quantitative Research by QYResearch Medical

The global lung in vitro market size was USD 273.7 million in 2020 and is expected to register a robust CAGR of 17.9% during the forecast period.

November 14, 2022
·
7 min read